Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 65% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Guðmundur Pálmason steps down from Enzymatica’s Board of Directors

By Modular Finance

Enzymatica AB (publ) announces that Guðmundur Pálmason has decided to step down from the company’s Board of Directors for personal reasons, effective 28 October 2026.

Guðmundur Pálmason has served on Enzymatica’s Board of Directors since February 2016. Prior to joining the Board, he served for approximately 20 years as Chairman of Zymetech ehf. (now Enzymatica ehf.), the Icelandic enzyme technology company acquired by Enzymatica in 2016.

“Guðmundur has been an important part of Enzymatica for many years and, on behalf of the Board, I would like to thank him for his longstanding commitment and valuable contributions to the company. We wish him all the best for the future,” says Bengt Baron, Chairman of the Board of Enzymatica.

Following Guðmundur Pálmason’s departure, Enzymatica’s Board of Directors will consist of five members.

For more information, please contact:
Bengt Baron, Chairman of the Board, Enzymatica AB
E-mail: bengt.baron@outlook.com

About Enzymatica AB
Enzymatica AB (publ) is a Swedish life science company that develops scientifically documented solutions for the treatment and relief of upper respiratory infections and related symptoms, based on a unique barrier technology platform. Enzymatica is headquartered in Lund, Sweden, and is listed on Nasdaq First North Growth Market. The company’s Certified Adviser is DNB Carnegie Investment Bank AB (publ).

Attachments
Guðmundur Pálmason steps down from Enzymatica’s Board of Directors

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.